PMID- 22256579
OWN - NLM
STAT- MEDLINE
DCOM- 20120214
LR  - 20181201
IS  - 0021-4892 (Print)
IS  - 0021-4892 (Linking)
VI  - 60
IP  - 12
DP  - 2011 Dec
TI  - [Anesthetic management for electroconvulsive therapy using rocuronium bromide and 
      sugammadex sodium in a patient with suspected malignant syndrome].
PG  - 1384-6
AB  - A 62-year-old woman was treated for schizophrenia for 40 years. When the symptoms 
      had deteriorated and new medications had to be added, CPK rose and she malignant 
      syndrome was suspected. The electroconvulsive therapy (ECT) was proposed because 
      of no improvement of the symptoms. We employed rocuronium bromide instead of 
      suxamethonium considering malignant syndrome. The maintenance of anesthesia was 
      necessary, because the duration of rocuronium bromide is longer than that of 
      suxamethonium chloride. Anesthesia was induced and maintained using target 
      controlled infusion (TCI) of propofol. After ECT was performed, sugammadex sodium 
      4 mg . kg-1 was administered at 2 post-tetanic counts (PTC) and the patient could 
      come out the operating room safely and speedy. ECT using rocuronium bromide and 
      sugammadex sodium can be performed safely and speedily, when suxamethonium 
      chloride cannot be used.
FAU - Maeda, Tsuyoshi
AU  - Maeda T
AD  - Department of Anesthesiology, Juntendo University Urayasu Hospital, Urayasu 
      279-0021.
FAU - Enomoto, Tatsuya
AU  - Enomoto T
FAU - Kamiyama, Yoichiro
AU  - Kamiyama Y
FAU - Inada, Eiichi
AU  - Inada E
LA  - jpn
PT  - Case Reports
PT  - Journal Article
PL  - Japan
TA  - Masui
JT  - Masui. The Japanese journal of anesthesiology
JID - 0413707
RN  - 0 (Androstanols)
RN  - 0 (Neuromuscular Nondepolarizing Agents)
RN  - 0 (gamma-Cyclodextrins)
RN  - 361LPM2T56 (Sugammadex)
RN  - WRE554RFEZ (Rocuronium)
SB  - IM
MH  - Androstanols/*administration & dosage/antagonists & inhibitors
MH  - *Anesthesia, General
MH  - Electroconvulsive Therapy/*methods
MH  - Female
MH  - Humans
MH  - Middle Aged
MH  - Neuroleptic Malignant Syndrome/*therapy
MH  - Neuromuscular Nondepolarizing Agents/*administration & dosage
MH  - Rocuronium
MH  - Sugammadex
MH  - gamma-Cyclodextrins/*administration & dosage/pharmacology
EDAT- 2012/01/20 06:00
MHDA- 2012/02/15 06:00
CRDT- 2012/01/20 06:00
PHST- 2012/01/20 06:00 [entrez]
PHST- 2012/01/20 06:00 [pubmed]
PHST- 2012/02/15 06:00 [medline]
PST - ppublish
SO  - Masui. 2011 Dec;60(12):1384-6.